Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Changes in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.

Matloff ET, Bonadies DC, Moyer A, Brierley KL.

J Genet Couns. 2014 Apr;23(2):164-71. doi: 10.1007/s10897-013-9625-z. Epub 2013 Jul 13.

PMID:
23852268
[PubMed - in process]
2.

What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.

Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN.

J Clin Oncol. 2000 Jun;18(12):2484-92.

PMID:
10856109
[PubMed - indexed for MEDLINE]
Free Article
3.

Erratum to: Changes in Specialists' Perspectives on Cancer Genetic Testing, Prophylactic Surgery and Insurance Discrimination: Then and Now.

Matloff ET, Bonadies DC, Moyer A, Brierley KL.

J Genet Couns. 2013 Aug 6. [Epub ahead of print] No abstract available.

PMID:
23918628
[PubMed - as supplied by publisher]
4.
5.

Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.

Julian-Reynier C, Eisinger F, Moatti JP, Sobol H.

Eur J Hum Genet. 2000 Mar;8(3):204-8.

PMID:
10780786
[PubMed - indexed for MEDLINE]
Free Article
6.

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.

Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW.

Breast J. 2004 Nov-Dec;10(6):475-80.

PMID:
15569201
[PubMed - indexed for MEDLINE]
7.

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

Cancer. 2006 Dec 15;107(12):2745-51.

PMID:
17109443
[PubMed - indexed for MEDLINE]
Free Article
8.

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.

Rueth NM, McMahon M, Arrington AK, Swenson K, Leach J, Tuttle TM.

Ann Surg Oncol. 2011 Sep;18(9):2515-20. doi: 10.1245/s10434-011-1642-2. Epub 2011 Mar 18.

PMID:
21424371
[PubMed - indexed for MEDLINE]
9.

Attitudes and practice of genetic counselors regarding anonymous testing for BRCA1/2.

Ader T, Susswein LR, Callanan NP, Evans JP.

J Genet Couns. 2009 Dec;18(6):606-17. doi: 10.1007/s10897-009-9250-z. Epub 2009 Oct 2.

PMID:
19798553
[PubMed - indexed for MEDLINE]
10.

Evolving perspectives on genetic discrimination in health insurance among health care providers.

Huizenga CR, Lowstuter K, Banks KC, Lagos VI, Vandergon VO, Weitzel JN.

Fam Cancer. 2010 Jun;9(2):253-60. doi: 10.1007/s10689-009-9308-y.

PMID:
19967457
[PubMed - indexed for MEDLINE]
11.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.

J Clin Oncol. 2003 May 1;21(9):1675-81.

PMID:
12721241
[PubMed - indexed for MEDLINE]
Free Article
12.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

PMID:
21768580
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

J Clin Oncol. 2008 Mar 1;26(7):1093-7. doi: 10.1200/JCO.2007.12.6078. Epub 2008 Jan 14.

PMID:
18195327
[PubMed - indexed for MEDLINE]
Free Article
14.

Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.

Murphy RX Jr, Adkinson JM, Namey T, Eid S, Bleznak A.

Ann Plast Surg. 2010 May;64(5):684-7. doi: 10.1097/SAP.0b013e3181dba8dc. Erratum in: Ann Plast Surg. 2010 Jul;65(1):116. Adkinson, Joshua M [added].

PMID:
20395792
[PubMed - indexed for MEDLINE]
15.

Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.

Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.

J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x. Review.

PMID:
18271762
[PubMed - indexed for MEDLINE]
16.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID:
15863145
[PubMed - indexed for MEDLINE]
17.

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.

Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA.

J Med Genet. 2000 Nov;37(11):866-74.

PMID:
11073541
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years.

Landsbergen KM, Prins JB, Kamm YJ, Brunner HG, Hoogerbrugge N.

Fam Cancer. 2010 Jun;9(2):213-20. doi: 10.1007/s10689-009-9311-3.

PMID:
19967456
[PubMed - indexed for MEDLINE]
19.

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL.

J Natl Cancer Inst. 1999 Sep 1;91(17):1475-9.

PMID:
10469748
[PubMed - indexed for MEDLINE]
Free Article
20.

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.

Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G.

Cancer Genet Cytogenet. 2006 Mar;165(2):91-7.

PMID:
16527602
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk